HENDERSON JOHN T

Average Profitability
43.23%
Insider Buys Quantity
6
Insider Buys Sum
$647,612.50
Insider Sells Quantity
19
Insider Sells Sum
$9.38M

Insider Activity of HENDERSON JOHN T

According to the SEC Form 4 filings, HENDERSON JOHN T, being in a position of

  1. director at Cytokinetics, Incorporated,
    оver the last 12 months, has bought 0 shares, and sold 23020 shares for $1.58M,
    over all time since 2019-11-19, has bought 6000 shares for $51,427, and sold 63539 shares for $3.43M.

The largest purchase of all time was on 2019-11-07 and amounted to 14000 shares of Myriad Genetics, Inc. for $328,446.

The largest sale of all time was on 2018-07-11 and amounted to 40000 shares of Myriad Genetics, Inc. for $1.51M.

Biography of HENDERSON JOHN T

No biography is available at this moment.

2024-04-25SaleCytokinetics, Incorporated
CYTK
director
10,562
0.0099%
$64.54$681,671-14.61%
2024-02-14SaleCytokinetics, Incorporated
CYTK
director
5,000
0.0049%
$76.48$382,400-25.39%
2024-01-12SaleCytokinetics, Incorporated
CYTK
director
5,000
0.0051%
$85.14$425,700-30.36%
2023-12-18SaleCytokinetics, Incorporated
CYTK
director
2,458
0.0025%
$36.34$89,324+65.71%
2023-05-15SaleCytokinetics, Incorporated
CYTK
director
4,166
0.0042%
$37.77$157,350-6.75%
2022-09-12SaleCytokinetics, Incorporated
CYTK
director
21,759
0.0234%
$54.95$1.2M-29.62%
2021-11-05SaleCytokinetics, Incorporated
CYTK
director
8,503
0.0098%
$40.00$340,120-1.9%
2021-04-01SaleCytokinetics, Incorporated
CYTK
director
2,233
0.003%
$23.66$52,833+35.15%
2020-12-31SaleCytokinetics, Incorporated
CYTK
director
858
0.0012%
$20.31$17,426+23.32%
2020-10-05SaleCytokinetics, Incorporated
CYTK
director
3,000
0.0047%
$29.00$87,000-22.61%
2019-11-19PurchaseCytokinetics, Incorporated
CYTK
director
6,000
0.0097%
$8.57$51,427+75.35%
2019-11-07PurchaseMyriad Genetics, Inc.
MYGN
director
14,000
0.0188%
$23.46$328,446-38.53%
2018-07-11SaleMyriad Genetics, Inc.
MYGN
director
40,000
0.0479%
$37.64$1.51M-25.91%
2017-09-01SaleMyriad Genetics, Inc.
MYGN
director
40,000
0.0517%
$26.84$1.07M+13.85%
2017-02-23PurchaseMyriad Genetics, Inc.
MYGN
director
8,000
0.0115%
$18.58$148,634+51.97%
2017-02-22PurchaseMyriad Genetics, Inc.
MYGN
director
4,000
0.0059%
$18.81$75,226+53.56%
2016-09-12SaleMyriad Genetics, Inc.
MYGN
director
4,014
0.0056%
$20.21$81,136-7.52%
2016-09-09SaleMyriad Genetics, Inc.
MYGN
director
55,986
0.0624%
$15.56$870,974-4.68%
2014-06-05SaleMyriad Genetics, Inc.
MYGN
director
10,000
0.0081%
$21.65$216,511+2.2%
2014-03-07SaleMyriad Genetics, Inc.
MYGN
director
40,000
0.0323%
$22.73$909,196-4.01%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.